MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, AIM made $26K in revenue. -$3,284K in net income. Net profit margin of -12630.77%.

Income Overview

Revenue
$26K
Net Income
-$3,284K
Net Profit Margin
-12630.77%
EPS
$1.57
Unit: Thousand (K) dollars
Revenue Breakdown
    • Clinical treatment programs - us

Income Statement
2025-09-30
2025-06-30
2024-12-31
2024-09-30
Total revenues
26 25 42.5 35
Production costs
68 10 7* 8
Research and development
607 1,174 2,324* 1,437
General and administrative
1,798 1,487 7,099* 3,079
Total costs and expenses
2,473 2,671 9,429.5 4,524
Operating loss
-2,447 -2,646 -9,387* -4,489
Interest and other income
-10 245* 718
Gain (loss) on investments
-1 -9 -375* 273
Interest and other income
3,052 ---
Interest expense and other finance costs
148 149 14* 202
Issuance cost
433 ---
(gain) on warrant issuance
--916* -
Loss on issuance of warrants
-3,977 0 --
(loss) gain from sale of income tax operating losses
--401* -
Change in fair value of warrants
-670 ---
Net loss
-3,284 -2,794 -9,016 -3,700
Basic EPS
1.57 -3.68 -0.157 -0.06
Diluted EPS
1.57 -3.68 -0.157 -0.06
Basic Average Shares
2,093,446 759,289 57,536,117 57,677,016
Diluted Average Shares
2,093,446 759,289 57,536,117 57,677,016
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$3,284K (11.24%↑ Y/Y)Interest and other income$3,052K (325.07%↑ Y/Y)Change in fair value ofwarrants-$670K Clinical treatmentprograms - us$26K Loss on issuance ofwarrants-$3,977K Operating loss-$2,447K (45.49%↑ Y/Y)Total revenues$26K (-25.71%↓ Y/Y)Issuance cost$433K Interest expense andother finance costs$148K (-26.73%↓ Y/Y)Gain (loss) oninvestments-$1K (-100.37%↓ Y/Y)Total costs andexpenses$2,473K (-45.34%↓ Y/Y)General andadministrative$1,798K (-41.60%↓ Y/Y)Research and development$607K (-57.76%↓ Y/Y)Production costs$68K (750.00%↑ Y/Y)

AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Inc. (AIM)